Post by
up2005 on Nov 01, 2022 12:46pm
Another divergence to push profitability down the road.
The companies technology is noteworthy, but they have this shotgun approach to entering the market. Pick a vertical sector and push hard on it. We are chasing, Gold, Lithium, Cannabis, Covid, E. coli, Listria, Salmonella.
The company is running out of both MONEY and TIME to deliver. It shouldn't take this long to commercialize these applications. How do they do a aisle at this share price 5 cents with killing the deal.
Comment by
throwaway11 on Nov 01, 2022 4:43pm
It should be clarified, up2005, that the research being conducted on developing the Escherichia Coli detection test is being paid for by a grant, and much of the research is being done at York University. Not at SIXW expense.
Comment by
up2005 on Nov 01, 2022 11:30pm
I have seen this Grant money being issued at various universities and colleges for endless testing and report writing and at the end no Purchase Orders ar on the table. Sure it's nice that SIXW doesn't have to pay the bill. This food borne detection testing would be a massive market so lets make it work!